Skip to content

PLSM

Pulsenmore Ltd.

NASDAQ · Healthcare · Medical - Devices · IL

$2.22
−8.45%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue54.5M40.0M9.6M6.1M10.6M
Cost of Revenue15.5M6.3M7.6M6.1M6.7M
Gross Profit39.1M33.7M2.1M39.7K3.9M
Operating Expenses
R&D Expense42.1M17.4M18.9M30.1M28.3M
SG&A Expense57.5M10.6M34.0M32.6M29.3M
General & Admin Expense9.3M5.5M17.2M19.0M16.8M
Selling & Marketing Expense5.1M5.1M16.8M13.6M12.6M
Other Expenses10.0M17.9M(8.7M)(7.5M)(8.5M)
Total Operating Expenses109.6M45.8M44.2M55.2M49.1M
Cost and Expenses125.0M52.2M51.8M61.2M55.8M
Operating Income (EBIT)(70.5M)(12.2M)(42.1M)(55.1M)(45.3M)
Non-Operating
Interest Income7.9M3.5M5.3M6.8M3.0M
Interest Expense20.4M315.0K538.8K605.8K341.8K
Net Interest Income(12.5M)3.2M4.8M6.2M2.7M
Other Non-Op Income/Expense(19.3M)(3.7M)5.4M(2.8M)23.6M
Non-Operating Income (excl Interest)597.2K3.4M(5.9M)2.2M(23.9M)
EBT (Pre-Tax Income)(89.8M)(15.9M)(36.7M)(57.9M)(21.7M)
Income Tax Expense(107.1K)1.0K(55.9K)125.9K
Bottom Line
Net Income(89.7M)(15.9M)(36.7M)(58.1M)(21.7M)
Earnings from Cont. Ops(89.7M)(15.9M)(36.7M)(58.1M)(21.7M)
Earnings from Discont. Ops
Bottom Line Net Income(89.7M)(15.9M)(36.7M)(58.1M)(21.7M)
Per Share
Basic EPS($13.97)($2.47)($5.71)($9.07)($3.58)
Diluted EPS($13.97)($2.47)($5.71)($9.07)($3.58)
Revenue Per Share$8.38$6.23$1.51$0.96$1.76
Shares
Basic Shares Outstanding6.5M6.4M6.4M6.4M6.0M
Diluted Shares Outstanding6.5M6.4M6.4M6.4M6.0M
Profitability Metrics
EBITDA(64.2M)(12.7M)(33.3M)(55.0M)(20.1M)
D&A6.9M2.8M2.8M2.4M1.3M
EBIT(71.1M)(15.5M)(36.2M)(57.3M)(21.3M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026